Sino Biopharmaceutical Limited (SBHMY)
OTCMKTS · Delayed Price · Currency is USD
20.16
0.00 (0.00%)
At close: Aug 27, 2025

Sino Biopharmaceutical Statistics

Total Valuation

SBHMY has a market cap or net worth of 19.83 billion. The enterprise value is 20.47 billion.

Market Cap19.83B
Enterprise Value 20.47B

Important Dates

The last earnings date was Monday, August 25, 2025.

Earnings Date Aug 25, 2025
Ex-Dividend Date Aug 29, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -2.10%
Shares Change (QoQ) -0.85%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 8.81B

Valuation Ratios

The trailing PE ratio is 36.70 and the forward PE ratio is 32.01.

PE Ratio 36.70
Forward PE 32.01
PS Ratio 4.65
PB Ratio 3.10
P/TBV Ratio 4.70
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 37.88
EV / Sales 4.76
EV / EBITDA 21.18
EV / EBIT 25.46
EV / FCF n/a

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.26.

Current Ratio 1.36
Quick Ratio 1.14
Debt / Equity 0.26
Debt / EBITDA 1.73
Debt / FCF n/a
Interest Coverage 21.69

Financial Efficiency

Return on equity (ROE) is 15.40% and return on invested capital (ROIC) is 6.55%.

Return on Equity (ROE) 15.40%
Return on Assets (ROA) 5.07%
Return on Invested Capital (ROIC) 6.55%
Return on Capital Employed (ROCE) 11.47%
Revenue Per Employee 185,063
Profits Per Employee 23,438
Employee Count24,379
Asset Turnover 0.43
Inventory Turnover 2.83

Taxes

In the past 12 months, SBHMY has paid 120.07 million in taxes.

Income Tax 120.07M
Effective Tax Rate 11.27%

Stock Price Statistics

The stock price has increased by +152.00% in the last 52 weeks. The beta is 0.64, so SBHMY's price volatility has been lower than the market average.

Beta (5Y) 0.64
52-Week Price Change +152.00%
50-Day Moving Average 9.51
200-Day Moving Average 14.58
Relative Strength Index (RSI) 85.12
Average Volume (20 Days) 930

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SBHMY had revenue of 4.27 billion and earned 540.39 million in profits. Earnings per share was 0.03.

Revenue4.27B
Gross Profit 3.49B
Operating Income 801.24M
Pretax Income 1.07B
Net Income 540.39M
EBITDA 962.63M
EBIT 801.24M
Earnings Per Share (EPS) 0.03
Full Income Statement

Balance Sheet

The company has 2.77 billion in cash and 1.67 billion in debt, giving a net cash position of 1.10 billion.

Cash & Cash Equivalents 2.77B
Total Debt 1.67B
Net Cash 1.10B
Net Cash Per Share n/a
Equity (Book Value) 6.39B
Book Value Per Share 0.26
Working Capital 1.25B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 81.77%, with operating and profit margins of 18.78% and 12.67%.

Gross Margin 81.77%
Operating Margin 18.78%
Pretax Margin 24.96%
Profit Margin 12.67%
EBITDA Margin 22.56%
EBIT Margin 18.78%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.97%.

Dividend Per Share 0.20
Dividend Yield 0.97%
Dividend Growth (YoY) 49.14%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 2.10%
Shareholder Yield 3.06%
Earnings Yield 2.72%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 14, 2020. It was a forward split with a ratio of 1.5.

Last Split Date Aug 14, 2020
Split Type Forward
Split Ratio 1.5

Scores

Altman Z-Score n/a
Piotroski F-Score 5